IMM Investment

Founded 1999


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 29
Average round size
The average size of a deal this fund participated in
Portfolio companies 25
Rounds per year 1.32
Lead investments 2
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 3
Key employees 4

Areas of investment

  • Marketplace
  • Mobile Apps
  • E-Commerce
  • Biotechnology
  • Artificial Intelligence

The venture was found in Asia in South Korea. The main department of described VC is located in the Seoul.

We can highlight the next thriving fund investment areas, such as Restaurants, Apps. Among the various public portfolio startups of the fund, we may underline Woowa Brothers, True Balance, Baedal Minjeok For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little.

We also calculated 4 valuable employees in our database.

When the investment is from IMM Investment the average startup value is more than 1 billion dollars. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2019.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the IMM Investment, startups are often financed by Capstone Partners Co., Ltd., Bon Angels Venture Partners, Altos Ventures. The meaningful sponsors for the fund in investment in the same round are Altos Ventures, Stonebridge Capital, Smilegate Investment. In the next rounds fund is usually obtained by Altos Ventures, IBK Capital, Goldman Sachs.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of IMM Investment:
Typical Co-investors
IMM Investment is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after IMM Investment:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Central Texas Angel Network United States, Austin
Cornerstone OnDemand United States, Santa Monica
Trellas Enterprises Cyprus, Nicosia
Hairong High Tech -
Natural Products Canada Canada, Charlottetown
EXA Ventures -
Inspired Evolution Investment Management South Africa, NA - South Africa
CardinalStone Capital Advisers Nigeria, Lagos
Dimension Japan, Tokyo
DIMENSION Japan, Chiyoda
MetaProp United States, New York

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Hugel Control

$1B25 Aug 2021 Gyeonggi-do South Korea


Artificial Intelligence
Machine Learning
Professional Services
$44M23 Jul 2021 Gyeonggi-do South Korea

Orum Therapeutics

Health Care
$54M23 Jun 2021 Gyeonggi-do South Korea


$5M22 Aug 2020 Hanoi Vietnam


Collaborative Consumption
$37M28 Jul 2020 Gyeonggi-do South Korea


$14M18 Jun 2020 Gyeonggi-do South Korea

Natural Resources
$40M28 Apr 2020 China Shanghai

H2O Hospitality

Housekeeping Service
Property Development
Property Management
Real Estate Investment
Vacation Rental
$7M03 Feb 2020 Chiyoda Japan


Artificial Intelligence
Computer Vision
Health Diagnostics
Image Recognition
Machine Learning
Medical Device
$26M07 Jan 2020 Gyeonggi-do South Korea
GenEdit Announces Series A Financing and Provides Research Update at TIDES 2021

– GenEdit has closed a $26m Series A financing.
– New investors include Eli Lilly, KTB Network, Company K Partners, Korea Investment Partners, DAYLI Partners, KB Investment, IMM Investment, and TIMEFOLIO Asset Management.
– The funding will support the further development of GenEdit’s NanoGalaxy™ platform of non-viral, non-lipid polymer nanoparticles, and the selection for clinical development of therapeutic candidates targeting diseases of the nervous system.

Orum Therapeutics Closes $84 Million Series B Financing to Advance Novel Targeted Protein Degrader Payloads into Clinical Trials for Cancer

– Orum Therapeutics closed a $84m Series B financing.
– The financing was led by IMM Investment and joined by new investors (KDB Investment and Atinum, among others) and existing investors (Intervest and KB Investment, among others).
– Orum plans to use the proceeds to advance the Company’s lead therapeutic candidates into clinical trials, explore additional payload chemistries to develop additional payloads that modulate the ubiquitin pathway, and other general corporate purposes.
– The company has developed a new class of ADC payloads, called neoDegraders, to specifically degrade intracellular target proteins within cancer cells via the E3 ubiquitin ligase pathway.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent IMM Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: